Skip to main content
OpenTrials
Completed

NCT Number: NCT05134064

68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Dual-time point 68Ga-PSMA PET/CT could increase the lesion detection in PCa patients, it remains difficult to perform in clinical practice. The possibility of one-time point 68Ga-PSMA PET/CT imaging could be achieved using a total-body PET/CT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

PET/CT Image Prostate Specific Membrane Antigen

Sex eligibility

Male

Study type

Observational

Primary location

Shanghai jiaotong University School of Medicine, Renji Hospital

Shanghai, Shanghai Municipality, 200127, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary staging of pathology-confirmed PCa or evidence of BCR with PSA value > 0.2 ng/ml
  • positive 68Ga-PSMA findings
  • both standard and delayed scans were performed on the total-body PET/CT

Exclusion criteria

  • only one scan was performed
  • negative PSMA results

Treatment and study plan

total-body PET/CT

Device

PCa patients who underwent PSMA PET/CT in our clinical center received two-time points scans at 1 h p.i. and 3 h p.i. on a total-body PET/CT scanner.

Primary outcomes

  1. Only one-time point scan is possible for PSMA PET/CT

    Time frame: 8 months

    By the use of total- body PET/CT scanner, the imaging quality between the 1 h p.i. and 3 h p.i. imaging acquisition are compared. And the different lesion detection rates at 3 h p.i. and 1 h p.i. are also discussed. The uptake value differences of all lesions are compared.

Sponsors and collaborators

Lead sponsor

RenJi Hospital

Other

Registry information

Official study title

68Ga-PSMA PET/CT Imaging in Assessment of PCa: Feasibility of Delayed Acquisition on Total-body PET/CT Scanner?

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Nov 24, 2021
Registry last updated
Nov 24, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.